About 5 results found for searched term "LSTA1" (0.124 seconds)
Cat.No. | Name | Target |
---|---|---|
M21358 | Certepetide | Integrin |
CEND-1; iRGD; LSTA1 | ||
Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating peptide whose RGD motif interacts with alphav-integrins and activates neurofibrillary protein 1 (NRP-1) to transform the solid tumor microenvironment into a temporary drug pipeline. Sequence Shortening: Ac-CRGDKGPDC-NH2 (Disulfide bridge: Cys1-Cys9). | ||
M43909 | LSTA1 | Others |
LSTA1 is a novel tumor-targeting penetrating peptide that enables compounds to penetrate tumors more efficiently and accumulate in tumors by activating tumor-specific transport systems. It can be used in studies related to solid tumors. | ||
M14532 | Avoralstat | Serine/Threonine Protease |
BCX4161 | ||
Avoralstat (BCX4161), a potent and orally active plasma kallikrein (PKK) inhibitor, is used for hereditary angioedema research. | ||
M21530 | Sebetralstat | Serine/Threonine Protease |
KVD900 | ||
Sebetralstat is an orally active plasma kininase (KLKB1) inhibitor for studies related to hereditary angioedema (HAE). | ||
M31399 | Rencofilstat | Cyclophilin |
RCF; CRV431 | ||
Rencofilstat (CRV431) is a cyclosporine derivative as well as an orally active cycloheximide (CYPA) inhibitor for studies related to non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.